top of page
Search

US Pediatric Hematologist-Oncologist Compensation Reaches $271,021 in Doximity’s 2026 Report

Writer: nuaxia
nuaxia
Sep 7
3 min read

Average annual compensation for US pediatric hematology and oncology physicians reached $271,021 in Doximity’s 2026 Physician Compensation Report, providing an updated national benchmark for physicians working in pediatric hematology and oncology.

US pediatric hematology and oncology physicians recorded average annual compensation of $271,021, according to Doximity’s 2026 Physician Compensation Report. The latest figure provides pediatric hematologist-oncologists with a specialty-specific benchmark when evaluating compensation, employment opportunities and the financial expectations associated with their practice.

Key findings

Doximity reports average annual compensation of $271,021 for Pediatric Hematology & Oncology physicians in its 2026 Physician Compensation Report.

For pediatric hematologist-oncologists, the figure provides a useful national reference point within a specialty focused on blood disorders and cancers affecting infants, children and adolescents.

The national average should not be interpreted as the compensation every pediatric hematologist-oncologist will receive. Individual earnings can vary according to geography, experience, patient complexity, disease focus, inpatient responsibilities, call commitments, practice setting and employment structure.

Pediatric hematologist-oncologist compensation reaches $271,021

The $271,021 average establishes a current national compensation benchmark for US pediatric hematologist-oncologists.

Pediatric hematology and oncology encompasses the diagnosis and treatment of childhood cancers alongside malignant and non-malignant blood disorders.

Physicians may care for children with leukemia, lymphoma, solid tumours, sickle cell disease, bleeding and clotting disorders, bone marrow failure syndromes and other complex hematological conditions.

Clinical practice frequently combines longitudinal outpatient management with inpatient care, treatment monitoring and coordination with multidisciplinary teams.

Some physicians may also work within stem cell transplantation, cellular therapy, survivorship or other highly specialised programmes, creating substantial variation in clinical responsibilities between individual positions.

For pediatric hematologist-oncologists reviewing their current compensation or considering a new position, the Doximity figure provides a useful specialty-specific reference against which an individual package can be assessed.

What influences pediatric hematologist-oncologist compensation?

Pediatric hematology and oncology involves the management of serious and frequently complex diseases, meaning patient complexity, disease mix, inpatient responsibilities and specialist expertise can all be important when evaluating individual compensation.

A physician caring predominantly for children receiving intensive cancer treatment may have a different workload from one whose practice contains a greater proportion of non-malignant hematological disorders.

Inpatient and call responsibilities can also be significant, particularly where physicians manage children undergoing intensive chemotherapy, stem cell transplantation or treatment for acute complications.

Clinical roles may additionally include participation in multidisciplinary tumour boards, long-term survivorship programmes and clinical research.

Geography, experience and employment model may further influence compensation. Pediatric hematologist-oncologists frequently work within children's hospitals, academic medical centres and specialist cancer programmes.

These factors mean the $271,021 national average should be treated as a benchmark rather than an expected salary for every pediatric hematologist-oncologist.

What the latest figure means for pediatric hematologist-oncologists

For US pediatric hematologist-oncologists, $271,021 provides a contemporary national reference point when benchmarking existing compensation or assessing a prospective position.

Physicians should consider headline compensation alongside patient complexity, disease mix, inpatient responsibilities, call frequency, treatment workload, research commitments and productivity requirements.

The precise clinical focus of the position is particularly important. Two pediatric hematology and oncology roles can involve substantially different responsibilities depending on the balance between malignant and non-malignant disease, inpatient coverage and involvement in transplantation, cellular therapy or other specialist programmes.

The latest Doximity figure therefore provides pediatric hematologist-oncologists with a useful starting point for evaluating compensation while recognising that individual earnings can differ substantially according to the clinical and contractual characteristics of a particular role.

About the data

The Doximity 2026 Physician Compensation Report provides compensation benchmarks across a wide range of US medical and surgical specialties.

The specialty figures represent average compensation and should be treated as national benchmarks. An individual pediatric hematologist-oncologist’s compensation may differ according to geography, experience, patient complexity, disease focus, inpatient responsibilities, practice setting and other professional factors.

Source


Discover how nuaxia can support your next medical education initiative:

Comments

Rated 0 out of 5 stars.
No ratings yet
Add a rating
bottom of page